Patent details

Basic Information

Publication number:

EP3864053

PCT Application Number:

EP2020075332

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP207854407

PCT Publication Number:

WO2021048280

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

TREATMENT OF RMS BY SWITCHING THERAPY

French Title of Invention:

COMMUTATEUR D'OFATUMUMAB

German Title of Invention:

OFATUMUMAB-SCHALTER

SPC Number:

Dates

Filing date:

10/09/2020

Grant date:

05/07/2023

EP Publication Date:

18/08/2021

PCT Publication Date:

18/03/2021

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

05/07/2023

EP B1 Publication Date:

05/07/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

10/09/2040

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

28/06/2023

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

13/07/2023

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

ZIEHN, Marina

Address:

Switzerland (CH)

2

Name:

MERSCHHEMKE, Martin

Address:

Switzerland (CH)

3

Name:

PINGILI, Ratnakar

Address:

United States (US)

4

Name:

RAMANATHAN, Krishnan

Address:

Switzerland (CH)

5

Name:

HAERING, Dieter Adrian

Address:

Switzerland (CH)

6

Name:

BAGGER, Morten

Address:

Switzerland (CH)

Priority

1

Priority Number:

19196789

Priority Date:

11/09/2019

Priority Country:

European Patent Office (EPO) (EP)

2

Priority Number:

20154736

Priority Date:

30/01/2020

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

C07K 16/28; A61P 25/00; A61P 25/28;

Publication

European Patent Bulletin

1

Issue number:

202327

Publication date:

05/07/2023

Description:

Grant (B1)

2

Issue number:

202332

Publication date:

09/08/2023

Description:

Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:

30/09/2025

Annual Fee Number:

6

Annual Fee Amount:

66 Euro

Expected Payer:

Last Annual Fee Payment Date:

29/08/2024

Last Annual Fee Paid Number:

5

Last Annual Fee Paid Amount:

52 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
13/07/2023	Power Of Attorney	1
17/07/2023	Outgoing Correspondence	1